Cytori Therapeutics (CYTX) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
General and administrative: 1.94M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of $0.03, $0.06 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $2.5 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Herbalife reaffirms Q3 and full-year 2026 financial guidance
- HSBC Upgrades Bid Corp Ltd (BID:SJ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
